Compounds > 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol
Page last updated: 2024-11-04

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and Amphetamine-Related Disorders

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with Amphetamine-Related Disorders in 1 studies

3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol: RN given refers to (+/-)-isomer; RN, RRs & structure given in first source

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tournier, BB1
Steimer, T1
Millet, P1
Moulin-Sallanon, M1
Vallet, P1
Ibañez, V1
Ginovart, N1

Other Studies

1 other study available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and Amphetamine-Related Disorders

ArticleYear
Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
    The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:8

    Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Benzamides; Benzopyrans;

2013